Mapping a human cell gives researchers a view of subcellular architecture and sheds light on how cancer develops.

Sickle cell disease (SCD) altered CD8+ T-cell chromatin architecture, triggering ferroptosis and weakening antitumor immunity ...

Today some of the most aggressive solid tumor cancers remain stubbornly resistant to treatment. There are many reasons why ...

Cancer thrives by stealing nutrients. Tumors grow fast because they hijack the body’s resources—especially glucose and fatty ...

Blocking serotonin transporters with antidepressants boosted CD8 T cell function and enhanced immunotherapy response in mouse ...

Terence M. Williams, MD, PhD, discussed the phase 1 DINOMITE trial of radiation therapy and papaverine in rectal cancer at ...

Tumors are made up of millions of cells, and removing all of these cells surgically or eliminating them with medication ...

Biomedical engineers at Georgia Tech created a treatment that could one day unlock a universal strategy for treating some of ...

A vaccine that looks to prevent breast cancer by detecting cancer cells and destroying them before they develop into tumors ...

A lab-designed molecule developed and extensively studied could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer.

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...